DÄ internationalArchive10/2020Repeat radiation for local recurrence of head and neck tumors and in prostate cancer

Review article

Repeat radiation for local recurrence of head and neck tumors and in prostate cancer

Dtsch Arztebl Int 2020; 117: 167-74. DOI: 10.3238/arztebl.2020.0167

Grün, A; Kuhnt, T; Schlomm, T; Olze, H; Budach, V; Stromberger, C

For technical reasons, the English full text will be published approximately two weeks after the German print edition has been published.

Klinik für Radioonkologie und Strahlentherapie, Charité – Universitätsmedizin Berlin, Campus Virchow-Klinikum: Dr. med. Arne Grün, Prof. Dr. med. Dr. h. c. Volker Budach,
PD Dr. med. Dr. med. univ. Carmen Stromberger
Charité CyberKnife Centrum Berlin, Charité – Universitätsmedizin Berlin,
Campus Virchow-Klinikum: Dr. med. Arne Grün, Prof. Dr. med. Dr. h. c. Volker Budach,
PD Dr. med. Dr. med. univ. Carmen Stromberger
Klinik für Strahlentherapie Universitätsklinikum Leipzig: Prof. Dr. med. Thomas Kuhnt
Klinik für Urologie, Charité – Universitätsmedizin Berlin: Prof. Dr. med. Thorsten Schlomm
Klinik für Hals-, Nasen-, Ohrenheilkunde, Charité – Universitätsmedizin Berlin,
Campus Virchow-Klinikum: Prof. Dr. med. Heidi Olze
1.Ling CC, Burman C, Chui CS, et al.: Conformal radiation treatment of prostate cancer using inversely-planned intensity-modulated photon beams produced with dynamic multileaf collimation. Int J of Radiat Oncol Biol Phys 1996; 35: 721–30 CrossRef
2.Romesser PB, Cahlon O, Scher ED, et al.: Proton beam reirradiation for recurrent head and neck cancer: Multi-institutional report on feasibility and early outcomes. Int J Radiat Oncol Biol Phys 2016; 95: 386–95 CrossRef MEDLINEPubMed Central
3.Lartigau EF, Tresch E, Thariat J, et al.: Multi institutional phase II study of concomitant stereotactic reirradiation and cetuximab for recurrent head and neck cancer. Radiother Oncol 2013; 109: 281–5 CrossRef MEDLINE
4.Li R, Ravizzini GC, Gorin MA, et al.: The use of PET/CT in prostate cancer. Prostate Cancer Prostatic Dis 2018; 21: 4–21 CrossRef MEDLINE
5.Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft DK, AWMF): Mundhöhlenkarzinom „Diagnostik und Therapie des Mundhöhlenkarzinoms“ AWMF-Register-Nummer (007–100OL). 2012.
6.Gravis G, Fizazi K, Joly F, et al.: Androgen-deprivation therapy alone or with docetaxel in non-castrate metastatic prostate cancer (GETUG-AFU 15): a randomised, open-label, phase 3 trial. Lancet Oncol 2013; 14: 149–58 CrossRef
7.Golbari NM, Katz AE: Salvage therapy options for local prostate cancer recurrence after primary radiotherapy: a literature review. Curr Urol Rep 2017; 18: 63 CrossRef MEDLINE
8.Yamazaki H, Demizu Y, Okimoto T, et al.: Reirradiation for recurrent head and neck cancers using charged particle or photon radiotherapy. Strahlenther Onkol 2017; 193: 525–33 CrossRef MEDLINE
9.Vargo JA, Ward MC, Caudell JJ, et al.: A multi-institutional comparison of SBRT and IMRT for definitive reirradiation of recurrent or second primary head and neck cancer. Int J radiat Oncol Biol Phys 2018; 100: 595–605 CrossRef MEDLINE
10.Davis KS, Vargo JA, Ferris RL, et al.: Stereotactic body radiotherapy for recurrent oropharyngeal cancer—influence of HPV status and smoking history. Oral Oncol 2014; 50: 1104–8 CrossRef MEDLINE
11.Shikama N, Kumazaki Y, Tsukamoto N, et al.: Validation of nomogram-based prediction of survival probability after salvage re-irradiation of head and neck cancer. Jpn J Clin Oncol 2013; 43: 154–60 CrossRef MEDLINE
12.Yamazaki H, Ogita M, Kodani N, et al.: Frequency, outcome and prognostic factors of carotid blowout syndrome after hypofractionated re-irradiation of head and neck cancer using CyberKnife: a multi-institutional study. Radiother Oncol 2013; 107: 305–9 CrossRef MEDLINE
13.Cvek J, Knybel L, Skacelikova E, et al.: Hyperfractionated stereotactic reirradiation for recurrent head and neck cancer. Strahlenther Onkol 2016; 192: 40–6 CrossRef MEDLINE
14.Rwigema JC, Heron DE, Ferris RL, et al.: Fractionated stereotactic body radiation therapy in the treatment of previously-irradiated recurrent head and neck carcinoma: updated report of the University of Pittsburgh experience. Am J Clin Oncol 2010; 33: 286–93 CrossRef MEDLINE
15.Yazici G, Sanli TY, Cengiz M, et al.: A simple strategy to decrease fatal carotid blowout syndrome after stereotactic body reirradiaton for recurrent head and neck cancers. Radiat Oncol 2013; 8: 242 CrossRef MEDLINE
16.Kodani N, Yamazaki H, Tsubokura T, et al.: Stereotactic body radiation therapy for head and neck tumor: disease control and morbidity outcomes. J Radiat Res 2011; 52: 24–31 CrossRef MEDLINE
17.Hayashi Y, Nakamura T, Mitsudo K, et al.: Re-irradiation using proton beam therapy combined with weekly intra-arterial chemotherapy for recurrent oral cancer. Asia Pac J Clin Oncol 2017; 13: e394-e401 CrossRef MEDLINE
18.Heron DE, Ferris RL, Karamouzis M, et al.: Stereotactic body radiotherapy for recurrent squamous cell carcinoma of the head and neck: results of a phase I dose-escalation trial. Int J Radiat Oncol Biol Phys 2009; 75: 1493–500 CrossRef MEDLINE
19.Karam I, Huang SH, McNiven A, et al.: Outcomes after reirradiation for recurrent nasopharyngeal carcinoma: North American experience. Head Neck 2016; 38 (Suppl 1): E1102–9 CrossRef MEDLINE
20.Chan OS, Sze HC, Lee MC, et al.: Reirradiation with intensity-modulated radiotherapy for locally recurrent T3 to T4 nasopharyngeal carcinoma. Head Neck 2017; 39: 533–40 CrossRef MEDLINE
21.Kakria A, Rawat S, Bhutani R, et al.: Retrospective analysis of treatment outcomes following reirradiation in locoregionally recurrent head and neck cancer patients: A single institutional study. Asia Pac J Clin Oncol 2015; 11: 129–34 CrossRef MEDLINE
22.Chang JH, Wu CC, Yuan KS, Wu ATH, Wu SY: Locoregionally recurrent head and neck squamous cell carcinoma: incidence, survival, prognostic factors, and treatment outcomes. Oncotarget 2017; 8: 55600–12 CrossRef
23.Fuller DB, Wurzer J, Shirazi R, Bridge SS, Law J, Mardirossian G: High-dose-rate stereotactic body radiation therapy for postradiation therapy locally recurrent prostatic carcinoma: Preliminary prostate-specific antigen response, disease-free survival, and toxicity assessment. Pract Radiat Oncol 2015; 5: e615–23 CrossRef MEDLINE
24.Janoray G, Reynaud-Bougnoux A, Ruffier-Loubiere A, Bernadou G, Pointreau Y, Calais G: Stereotactic body re-irradiation therapy for locally recurrent prostate cancer after external-beam radiation therapy: Initial report. Cancer Radiother 2016; 20: 275–81 CrossRef MEDLINE
25.Jereczek-Fossa BA, Beltramo G, Fariselli L, et al.: Robotic image-guided stereotactic radiotherapy, for isolated recurrent primary, lymph node or metastatic prostate cancer. Int J Radiat Oncol Biol Phys 2012; 82: 889–97 CrossRef MEDLINE
26.Mbeutcha A, Chauveinc L, Bondiau PY, et al.: Salvage prostate re-irradiation using high-dose-rate brachytherapy or focal stereotactic body radiotherapy for local recurrence after definitive radiation therapy. Radiat Oncol 2017; 12: 49 CrossRef MEDLINE PubMed Central
27.Loi M, Di Cataldo V, Simontacchi G, et al.: Robotic stereotactic retreatment for biochemical control in previously irradiated patients affected by recurrent prostate cancer. Clin Oncol (R Coll Radiol) 2018; 30: 93–100 CrossRef MEDLINE
28.Miszczyk L, Stapor-Fudzinska M, Miszczyk M, Maciejewski B, Tukiendorf A: Salvage cyberKnife-based reirradiation of patients with recurrent prostate cancer: The single-center experience. Technol Cancer Res Treat 2018; 17: 1533033818785496 CrossRef MEDLINE PubMed Central
29.Zerini D, Jereczek-Fossa BA, Fodor C, et al.: Salvage image-guided intensity modulated or stereotactic body reirradiation of local recurrence of prostate cancer. Br J Radiol 2015; 88: 20150197 CrossRef MEDLINE PubMed Central
30.Leroy T, Lacornerie T, Bogart E, et al.: Salvage robotic SBRT for local prostate cancer recurrence after radiotherapy: preliminary results of the Oscar Lambret Center.Radiat Oncol 2017; 12; doi.org/10.1186/s13014–017–0833–9 CrossRef MEDLINE PubMed Central
31.Barkan H: Statistics in clinical research: Important considerations. Ann Card Anaesth 2015; 18: 74–82 CrossRef MEDLINE PubMed Central
32.Haque W, Butler EB, Teh BS: Stereotactic body radiation therapy for prostate cancer-a review. Chin Clin Oncol 2017; 6: S10 CrossRef MEDLINE
33.Ceci F, Castellucci P, Graziani T, et al.: (68)Ga-PSMA-11 PET/CT in recurrent prostate cancer: efficacy in different clinical stages of PSA failure after radical therapy. Eur J Nucl Med Mol Imaging 2019; 46: 31–9 CrossRef MEDLINE
34.Eiber M, Maurer T, Souvatzoglou M, et al.: Evaluation of hybrid (6)(8)Ga-PSMA Ligand PET/CT in 248 patients with biochemical recurrence after radical prostatectomy. J Nucl Med 2015; 56: 668–74 CrossRef MEDLINE
35.Lutje S, Cohnen J, Gomez B, et al.: Integrated (68)Ga-HBED-CC-PSMA-PET/MRI in patients with suspected recurrent prostate cancer. Nuklearmedizin 2017; 56: 73–81 CrossRef MEDLINE